RxDoctor Payments DataLook up a doctor →

James Scowcroft, MD

Pain Medicine · Lees Summit, MONPI 1285615450

Payments from drug & device makers

$1,840,073in general payments, 2019–2025

Across 451 payments — averaging $4079.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Nevro Corp.$1.3M
  • Boston Scientific$445K
  • Saluda Medical Americas, Inc.$62K
  • Medtronic$485
  • Abbott$363
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$176
  • plus $1K from 21 others
$614in research payments, 2019–2025

Across 2 payments — averaging $307.08 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Nevro Corp.$429
  • Saluda Medical Americas, Inc.$185

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,840,073 in reported general payments places this provider in the 95th percentile of 124 pain medicine providers in Missouri.

See all pain medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$141,441
Medicare patients
511
Services billed
1,243

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other pain medicine in Lees Summit

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →